BCIQ Profiles

Company Profile Report
0305 QT PDev and Reg
BioCentury & Getty Images

Product Development

March 5 Quick Takes: A regulatory first for Actemra; plus updates from Lilly-Incyte, Kronos, Junshi, United Therapeutics, Pfizer, Sumitomo Dainippon, Arena, Oyster Point, Azura  

Mar 6, 2021 | 12:31 AM GMT

The Genentech Inc. unit of Roche (SIX:ROG; OTCQX:RHHBY) said FDA approved Actemra tocilizumab to treat systemic sclerosis-associated interstitial lung disease, making it the first approved biologic for the disorder. FDA based the approval on data from the Phase III focuSSced

Read the full 740 word article

How to gain access

Continue reading with a
two-week free trial.